AFM-Téléthon, a charitable organisation that raises funding for neuromuscular disease research and treatments, has launched an institute aimed at speeding up the development of treatments for rare diseases.
Launched on 27 September, the biotherapies institute brings together 650 researchers from four AFM-Téléthon funded laboratories.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.